The CFS and FM patient groups were significantly lower than controls in plasma levels for IL-1β, IL-4, IL-6, TNF-α, TGF-β1, TGF-β2, TGF-β3, IL-10 and IL-17A. The gene discussed is IL1B; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.